This report aims to provide a comprehensive presentation of the global market for Lung Cancer Screening Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Screening Software. This report contains market size and forecasts of Lung Cancer Screening Software in global, including the following market information:
Global Lung Cancer Screening Software Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Lung Cancer Screening Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cloud-Based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Screening Software include Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc. and Magview, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Screening Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Screening Software Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Lung Cancer Screening Software Market Segment Percentages, by Type, 2022 (%)
Cloud-Based
Web-Based
Global Lung Cancer Screening Software Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Lung Cancer Screening Software Market Segment Percentages, by Application, 2022 (%)
Control and Monitoring
Data Management
Decision Support
Global Lung Cancer Screening Software Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Lung Cancer Screening Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Screening Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lung Cancer Screening Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nuance Communications Inc.
Eon
Koninklijke Philips N.V.
Siemens Healthineers AG
PenRad Technologies Inc.
MRS Systems Inc.
Magview
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Screening Software, market overview.
Chapter 2: Global Lung Cancer Screening Software market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Screening Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Screening Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Screening Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Screening Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Screening Software Overall Market Size
2.1 Global Lung Cancer Screening Software Market Size: 2022 VS 2029
2.2 Global Lung Cancer Screening Software Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Screening Software Players in Global Market
3.2 Top Global Lung Cancer Screening Software Companies Ranked by Revenue
3.3 Global Lung Cancer Screening Software Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Screening Software Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Screening Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Screening Software Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Screening Software Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Screening Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Screening Software Market Size Markets, 2022 & 2029
4.1.2 Cloud-Based
4.1.3 Web-Based
4.2 By Type - Global Lung Cancer Screening Software Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Screening Software Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Screening Software Revenue, 2024-2029
4.2.3 By Type - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Screening Software Market Size, 2022 & 2029
5.1.2 Control and Monitoring
5.1.3 Data Management
5.1.4 Decision Support
5.2 By Application - Global Lung Cancer Screening Software Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Screening Software Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Screening Software Revenue, 2024-2029
5.2.3 By Application - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Lung Cancer Screening Software Market Size, 2022 & 2029
6.2 By Region - Global Lung Cancer Screening Software Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Screening Software Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Screening Software Revenue, 2024-2029
6.2.3 By Region - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Lung Cancer Screening Software Revenue, 2018-2029
6.3.2 US Lung Cancer Screening Software Market Size, 2018-2029
6.3.3 Canada Lung Cancer Screening Software Market Size, 2018-2029
6.3.4 Mexico Lung Cancer Screening Software Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Screening Software Revenue, 2018-2029
6.4.2 Germany Lung Cancer Screening Software Market Size, 2018-2029
6.4.3 France Lung Cancer Screening Software Market Size, 2018-2029
6.4.4 U.K. Lung Cancer Screening Software Market Size, 2018-2029
6.4.5 Italy Lung Cancer Screening Software Market Size, 2018-2029
6.4.6 Russia Lung Cancer Screening Software Market Size, 2018-2029
6.4.7 Nordic Countries Lung Cancer Screening Software Market Size, 2018-2029
6.4.8 Benelux Lung Cancer Screening Software Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Screening Software Revenue, 2018-2029
6.5.2 China Lung Cancer Screening Software Market Size, 2018-2029
6.5.3 Japan Lung Cancer Screening Software Market Size, 2018-2029
6.5.4 South Korea Lung Cancer Screening Software Market Size, 2018-2029
6.5.5 Southeast Asia Lung Cancer Screening Software Market Size, 2018-2029
6.5.6 India Lung Cancer Screening Software Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Lung Cancer Screening Software Revenue, 2018-2029
6.6.2 Brazil Lung Cancer Screening Software Market Size, 2018-2029
6.6.3 Argentina Lung Cancer Screening Software Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Screening Software Revenue, 2018-2029
6.7.2 Turkey Lung Cancer Screening Software Market Size, 2018-2029
6.7.3 Israel Lung Cancer Screening Software Market Size, 2018-2029
6.7.4 Saudi Arabia Lung Cancer Screening Software Market Size, 2018-2029
6.7.5 UAE Lung Cancer Screening Software Market Size, 2018-2029
7 Lung Cancer Screening Software Companies Profiles
7.1 Nuance Communications Inc.
7.1.1 Nuance Communications Inc. Company Summary
7.1.2 Nuance Communications Inc. Business Overview
7.1.3 Nuance Communications Inc. Lung Cancer Screening Software Major Product Offerings
7.1.4 Nuance Communications Inc. Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.1.5 Nuance Communications Inc. Key News & Latest Developments
7.2 Eon
7.2.1 Eon Company Summary
7.2.2 Eon Business Overview
7.2.3 Eon Lung Cancer Screening Software Major Product Offerings
7.2.4 Eon Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.2.5 Eon Key News & Latest Developments
7.3 Koninklijke Philips N.V.
7.3.1 Koninklijke Philips N.V. Company Summary
7.3.2 Koninklijke Philips N.V. Business Overview
7.3.3 Koninklijke Philips N.V. Lung Cancer Screening Software Major Product Offerings
7.3.4 Koninklijke Philips N.V. Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.3.5 Koninklijke Philips N.V. Key News & Latest Developments
7.4 Siemens Healthineers AG
7.4.1 Siemens Healthineers AG Company Summary
7.4.2 Siemens Healthineers AG Business Overview
7.4.3 Siemens Healthineers AG Lung Cancer Screening Software Major Product Offerings
7.4.4 Siemens Healthineers AG Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.4.5 Siemens Healthineers AG Key News & Latest Developments
7.5 PenRad Technologies Inc.
7.5.1 PenRad Technologies Inc. Company Summary
7.5.2 PenRad Technologies Inc. Business Overview
7.5.3 PenRad Technologies Inc. Lung Cancer Screening Software Major Product Offerings
7.5.4 PenRad Technologies Inc. Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.5.5 PenRad Technologies Inc. Key News & Latest Developments
7.6 MRS Systems Inc.
7.6.1 MRS Systems Inc. Company Summary
7.6.2 MRS Systems Inc. Business Overview
7.6.3 MRS Systems Inc. Lung Cancer Screening Software Major Product Offerings
7.6.4 MRS Systems Inc. Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.6.5 MRS Systems Inc. Key News & Latest Developments
7.7 Magview
7.7.1 Magview Company Summary
7.7.2 Magview Business Overview
7.7.3 Magview Lung Cancer Screening Software Major Product Offerings
7.7.4 Magview Lung Cancer Screening Software Revenue in Global Market (2018-2023)
7.7.5 Magview Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Screening Software Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Screening Software Market Drivers in Global Market
Table 3. Lung Cancer Screening Software Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Screening Software in Global Market
Table 5. Top Lung Cancer Screening Software Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Cancer Screening Software Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Cancer Screening Software Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Cancer Screening Software Product Type
Table 9. List of Global Tier 1 Lung Cancer Screening Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Screening Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Screening Software Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Lung Cancer Screening Software Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Cancer Screening Software Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Lung Cancer Screening Software Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Lung Cancer Screening Software Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Cancer Screening Software Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Lung Cancer Screening Software Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Lung Cancer Screening Software Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Cancer Screening Software Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Cancer Screening Software Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Cancer Screening Software Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Cancer Screening Software Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Cancer Screening Software Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Cancer Screening Software Revenue, (US$, Mn), 2024-2029
Table 30. Nuance Communications Inc. Company Summary
Table 31. Nuance Communications Inc. Lung Cancer Screening Software Product Offerings
Table 32. Nuance Communications Inc. Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 33. Nuance Communications Inc. Key News & Latest Developments
Table 34. Eon Company Summary
Table 35. Eon Lung Cancer Screening Software Product Offerings
Table 36. Eon Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 37. Eon Key News & Latest Developments
Table 38. Koninklijke Philips N.V. Company Summary
Table 39. Koninklijke Philips N.V. Lung Cancer Screening Software Product Offerings
Table 40. Koninklijke Philips N.V. Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 41. Koninklijke Philips N.V. Key News & Latest Developments
Table 42. Siemens Healthineers AG Company Summary
Table 43. Siemens Healthineers AG Lung Cancer Screening Software Product Offerings
Table 44. Siemens Healthineers AG Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 45. Siemens Healthineers AG Key News & Latest Developments
Table 46. PenRad Technologies Inc. Company Summary
Table 47. PenRad Technologies Inc. Lung Cancer Screening Software Product Offerings
Table 48. PenRad Technologies Inc. Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 49. PenRad Technologies Inc. Key News & Latest Developments
Table 50. MRS Systems Inc. Company Summary
Table 51. MRS Systems Inc. Lung Cancer Screening Software Product Offerings
Table 52. MRS Systems Inc. Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 53. MRS Systems Inc. Key News & Latest Developments
Table 54. Magview Company Summary
Table 55. Magview Lung Cancer Screening Software Product Offerings
Table 56. Magview Lung Cancer Screening Software Revenue (US$, Mn) & (2018-2023)
Table 57. Magview Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Screening Software Segment by Type in 2022
Figure 2. Lung Cancer Screening Software Segment by Application in 2022
Figure 3. Global Lung Cancer Screening Software Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Screening Software Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lung Cancer Screening Software Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2022
Figure 8. By Type - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 9. By Application - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 10. By Type - Global Lung Cancer Screening Software Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 12. By Application - Global Lung Cancer Screening Software Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 14. By Region - Global Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 15. By Country - North America Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 16. US Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 20. Germany Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 21. France Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 28. China Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 32. India Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 34. Brazil Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Lung Cancer Screening Software Revenue Market Share, 2018-2029
Figure 37. Turkey Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Lung Cancer Screening Software Revenue, (US$, Mn), 2018-2029
Figure 41. Nuance Communications Inc. Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eon Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Koninklijke Philips N.V. Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Siemens Healthineers AG Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PenRad Technologies Inc. Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. MRS Systems Inc. Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Magview Lung Cancer Screening Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
